| Measuring self-reported cancer-related cognitive impairment: recommendations from the cancer neuroscience initiative working group AM Henneghan, K Van Dyk, T Kaufmann, R Harrison, C Gibbons, ... JNCI: Journal of the National Cancer Institute 113 (12), 1625-1633, 2021 | 72 | 2021 |
| Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma at the end of life: insights from real‐world practice RB Parikh, MD Galsky, B Gyawali, F Riaz, TL Kaufmann, AB Cohen, ... The Oncologist 24 (6), e397-e399, 2019 | 39 | 2019 |
| Multiple hindered rotators in a gyroscope-inspired tribenzylamine hemicryptophane NS Khan, JM Perez-Aguilar, T Kaufmann, PA Hill, O Taratula, OS Lee, ... The Journal of organic chemistry 76 (5), 1418-1424, 2011 | 39 | 2011 |
| Oncology and palliative care integration: cocreating quality and value in the era of health care reform TL Kaufmann, AH Kamal Journal of Oncology Practice 13 (9), 580-588, 2017 | 37 | 2017 |
| Patient perspectives on chemotherapy de‐escalation in breast cancer GB Rocque, CP Williams, C Andrews, TC Childers, KD Wiseman, ... Cancer medicine 10 (10), 3288-3298, 2021 | 21 | 2021 |
| Views from patients with cancer in the setting of unplanned acute care: informing approaches to reduce health care utilization TL Kaufmann, KA Rendle, E Aakhus, V Nimgaonkar, A Shah, A Bilger, ... JCO oncology practice 16 (11), e1291-e1303, 2020 | 21 | 2020 |
| Pathway to precision patient-reported outcomes TL Kaufmann, GB Rocque Journal of Clinical Oncology 39 (34), 3770-3772, 2021 | 16 | 2021 |
| Identification of patient-reported outcome phenotypes among oncology patients with palliative care needs TL Kaufmann, KD Getz, JY Hsu, AV Bennett, SU Takvorian, AH Kamal, ... JCO oncology practice 17 (10), e1473-e1488, 2021 | 8 | 2021 |
| Making the right thing easier to do: standardized integration of oncology and palliative care AH Kamal, T Kaufmann Journal of Oncology Practice 13 (5), 291-292, 2017 | 8 | 2017 |
| Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma (aUC) at the end of life: Insights from real-world practice. RB Parikh, MD Galsky, B Gyawali, F Riaz, TL Kaufmann, AB Cohen, ... Journal of Clinical Oncology 37 (7_suppl), 395-395, 2019 | 2 | 2019 |
| Patient-Perceived Benefits and Limitations of Standard of Care Remote Symptom Monitoring During Cancer Treatment CS Smith, NL Henderson, EK Hendrix, T Padalkar, CHS Huang, ... Cancer Control 31, 10732748241297368, 2024 | | 2024 |
| Using Electronic Patient-Reported Outcome Monitoring to Navigate Patients to Supportive Care Services TL Kaufmann, GB Rocque JCO Oncology Practice 20 (10), 1297-1299, 2024 | | 2024 |
| Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer AM Henneghan, KM Van Dyk, D Haywood, M Patel, OY Franco-Rocha, ... Breast Cancer Research and Treatment, 1-14, 2024 | | 2024 |
| A Framework to Promote Implementation of Patient-Reported Outcomes in Institutions Caring for Vulnerable and Underserved Cancer Populations ALR Schuster, NL Crossnohere, EA Boakye, R Angove, B Baldwin, ... The Patient-Patient-Centered Outcomes Research, 1-7, 2024 | | 2024 |
| Characterization of remote symptom alerts generated from patient-reported outcome (PRO) symptom monitoring in a real-world breast cancer population. M Hurtado Castillo, E Rusli, D Wujcik, A Galaznik, TL Kaufmann Journal of Clinical Oncology 42 (16_suppl), e23193-e23193, 2024 | | 2024 |
| Pilot study of remote electronic patient-reported outcomes (ePRO) symptom monitoring of palliative care needs among outpatients with advanced solid cancers. TL Kaufmann, J Saxton, CE Smith, P Chang, K Sebastian, A Courtney, ... JCO Oncology Practice 19 (11_suppl), 250-250, 2023 | | 2023 |
| Abstract P5-07-12: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early Stage and Metastatic Breast Cancer T Kaufmann, A Galaznik, N Coombs, GB Rocque Cancer Research 83 (5_Supplement), P5-07-12-P5-07-12, 2023 | | 2023 |
| Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast … T Kaufmann, P Chang, S Rosenberg, E Frank, B Hobbs, LJ Bayne, I Nivar, ... Cancer Research 83 (5_Supplement), P5-08-01-P5-08-01, 2023 | | 2023 |
| Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group (vol 113, pg 1625, 2021) AM Henneghan, K Van Dyk, T Kaufmann, R Harrison, C Gibbons, ... JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 114 (12), 1731-1731, 2022 | | 2022 |
| Development of a patient-reported outcome measure (PROM) screening strategy for early palliative care needs in outpatients with advanced cancer. TL Kaufmann, GB Rocque, EA Kvale, A Kamal, M Pignone, AV Bennett, ... Journal of Clinical Oncology 40 (28_suppl), 203-203, 2022 | | 2022 |
